131 related articles for article (PubMed ID: 24492844)
1. B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy.
Kramann N; Hasenfuß G; Seidler T
Cardiovasc Res; 2014 Apr; 102(1):88-96. PubMed ID: 24492844
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Clerk A; Meijles DN; Hardyman MA; Fuller SJ; Chothani SP; Cull JJ; Cooper STE; Alharbi HO; Vanezis K; Felkin LE; Markou T; Leonard SJ; Shaw SW; Rackham OJL; Cook SA; Glennon PE; Sheppard MN; Sembrat JC; Rojas M; McTiernan CF; Barton PJ; Sugden PH
Biochem J; 2022 Feb; 479(3):401-424. PubMed ID: 35147166
[TBL] [Abstract][Full Text] [Related]
3. DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
Kuhn C; Frank D; Will R; Jaschinski C; Frauen R; Katus HA; Frey N
J Biol Chem; 2009 Jun; 284(25):17320-17327. PubMed ID: 19372220
[TBL] [Abstract][Full Text] [Related]
4. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1.
Clerk A; Pham FH; Fuller SJ; Sahai E; Aktories K; Marais R; Marshall C; Sugden PH
Mol Cell Biol; 2001 Feb; 21(4):1173-84. PubMed ID: 11158304
[TBL] [Abstract][Full Text] [Related]
6. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
7. PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.
Li J; Gao H; Huang J; Wang P; Huang Y; Luo W; Zhang X; Shen P; You J; Cai S; Li Z; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):15-23. PubMed ID: 27094369
[TBL] [Abstract][Full Text] [Related]
8. Raf-mediated cardiac hypertrophy in adult Drosophila.
Yu L; Daniels J; Glaser AE; Wolf MJ
Dis Model Mech; 2013 Jul; 6(4):964-76. PubMed ID: 23580199
[TBL] [Abstract][Full Text] [Related]
9. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy.
Kashiwase K; Higuchi Y; Hirotani S; Yamaguchi O; Hikoso S; Takeda T; Watanabe T; Taniike M; Nakai A; Tsujimoto I; Matsumura Y; Ueno H; Nishida K; Hori M; Otsu K
Biochem Biophys Res Commun; 2005 Feb; 327(1):136-42. PubMed ID: 15629441
[TBL] [Abstract][Full Text] [Related]
10. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.
Yue TL; Gu JL; Wang C; Reith AD; Lee JC; Mirabile RC; Kreutz R; Wang Y; Maleeff B; Parsons AA; Ohlstein EH
J Biol Chem; 2000 Dec; 275(48):37895-901. PubMed ID: 10984495
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat cardiomyocytes.
Yamazaki T; Komuro I; Zou Y; Kudoh S; Mizuno T; Hiroi Y; Shiojima I; Takano H; Kinugawa Ki; Kohmoto O; Takahashi T; Yazaki Y
J Mol Cell Cardiol; 1997 Sep; 29(9):2491-501. PubMed ID: 9299372
[TBL] [Abstract][Full Text] [Related]
12. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy.
Thorburn J; McMahon M; Thorburn A
J Biol Chem; 1994 Dec; 269(48):30580-6. PubMed ID: 7982977
[TBL] [Abstract][Full Text] [Related]
13. Adenosine kinase regulation of cardiomyocyte hypertrophy.
Fassett JT; Hu X; Xu X; Lu Z; Zhang P; Chen Y; Bache RJ
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1722-32. PubMed ID: 21335462
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro.
Autelitano DJ; Ridings R; Tang F
Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465
[TBL] [Abstract][Full Text] [Related]
15. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes.
Yamazaki T; Komuro I; Kudoh S; Zou Y; Shiojima I; Mizuno T; Takano H; Hiroi Y; Ueki K; Tobe K
J Clin Invest; 1995 Jul; 96(1):438-46. PubMed ID: 7615816
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
17. DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1.
Sun Y; Xu C; Jiang Z; Jiang X
Cell Death Dis; 2023 Jul; 14(7):483. PubMed ID: 37524688
[TBL] [Abstract][Full Text] [Related]
18. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
[TBL] [Abstract][Full Text] [Related]
20. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
